Anosha Altaf
Mohammad Ali Jinnah University, Karachi, Pakistan ![]()
Correspondence to: Anosha Altaf, Anoshaaltaf10@gmail.com

Additional information
- Ethical approval: N/a
- Consent: N/a
- Funding: No industry funding
- Conflicts of interest: N/a
- Author contribution: Anosha Altaf – Conceptualization, Writing – original draft, review and editing
- Guarantor: Anosha Altaf
- Provenance and peer-review: Unsolicited and externally peer-reviewed
- Data availability statement: N/a
Keywords: ACE I, ACTN3rs1815739, D polymorphism, Gene-environment interactions, Genetic injury susceptibility, VEGFArs699947
Peer Review
Received: 4 September 2025
Last revised: 22 January 2026
Accepted: 10 February 2026
Version accepted: 7
Published: 18 February 2026
Plain Language Summary Infographic

Abstract
The presented narrative literature review analyzes the interaction between genetic polymorphisms and environmental factors (training and nutrition) to define athletic performance and risk of injury. Genetic endurance, power, strength and risk of injury, was reviewed in a variety of sports including football, rugby and soccer. Significant genetic polymorphisms were found, such as ACTN3 rs1815739, ACE I/D and VEGFA rs699947, which influence the outcome of the performance and risk of injury. Also the significance of the genetic and environmental interaction, particularly in reaction to nutritional supplementation like iron and caffeine, was highlighted and personal training and nutritional habits were mentioned as crucial in realising the best in athletic performance. Despite high levels of correlation between the genetic factors and the athletic performance, it was apparent that elite performance is a complicated confluence of genetic predisposition and the environment which underscores the importance of treating individuals uniquely as far as training and injury prevention are concerned. The review will require more research in the enhancement of genetic testing technologies and translating them into practice in the field of sports science.
Highlights
- The genetic polymorphisms, including ACTN3 rs1815739 and ACE I/D, play a crucial role in determining the performance and the risk of injury in athletes.
- Interacting with the environment can play a key role in optimal performance, especially with personalised training and dietary plans.
- The VEGFA rs699947 polymorphism correlates with a reduced risk of injury among athletes, although it is only the C allele carriers.
- Iron supplementation and response to caffeine are dependent on the genetic composition of an athlete and will affect recovery and performance.
- Individual genetic testing is necessary to customise training and injury prevention methods in elite athletes.
Introduction
Genetics has always been identified as one of the crucial determinants of the athletic performance that predetermines such fundamental characteristics as power, strength, aerobic capacity, flexibility, coordination, and temperament.1 In some of the studies, it has been suggested that athlete status may be hereditary to a rate of up to 70% although this varies depending on the sport discipline.2 Although these numbers draw emphasis on the fact that genetic factors influence athletic performance quite significantly, the exact genomic variations involved in achieving athletic success remain a mystery to this day, and thus the topic has a lot to discover. A thorough examination was made on a genetic determinant of endurance and power-based exercise performance that further supported the fact that genetic polymorphisms influenced any significant athletic trait, including the way an athlete responds to different kinds of exercise, capable of adapting to training, and even their susceptibility to sports related injuries.3
A closer examination of the physiological factors that are of significance to endurance performance is likely to include maximal oxygen uptake (VO2 max), lactate threshold, and running economy.4 Despite the proven existence of such determinants in the study of exercise physiology, it has been alleged that the genetic factor of such traits has hardly been clearly understood. Relating specific genetic variations to these physiological variables has not been an easy task. Indicatively, a paper on polymorphism, including those of the PPARGC1A and NRF1 genes, has already given a clue about possible association with endurance performance, primarily through its involvement with muscle fibre composition and mitochondrial metabolism.5 However, the studies found out that the genetic influence on muscle fibre differentiation can be gender specific, and its influence is more effective among women.6
Over 200 genetic variations have been linked to developing athletic traits yet no single specific genetic signature has been established that can be reliable predictor of success in particular sports.7 This is a sign of complexity of athletic performance where different genetic factors interact in a manner that has been poorly understood. The latest developments in technologies such as genome-wide association studies8 and Total Genotype Scores (TGS) computation9 have provided a clearer insight into the mechanisms and systems by which athletic traits are determined. Nonetheless, none of these tools has been able to give conclusive answers on exact genetic markers of sport talent.
Despite the vast body of research on this topic, a complete understanding of the interplay between genetic markers and performance remains elusive.10,11 This narrative review aims to identify the current knowledge on the relationship between genetic polymorphisms and diverse aspects of sports performance, including endurance, power, muscle strength, and injury susceptibility. The narrative review will also look into the interactions of these genetic markers and environmental variables that can boost the performance of an athlete. The PEO framework has been adapted to guide the review. Population: Athletes across various sports (endurance, power, elite athletes, injury-prone athletes), Exposure: Genetic polymorphisms and their interaction with environmental and training factors, and Outcome: The influence of genetic factors on sports performance, injury susceptibility, training outcomes, and the prediction of athletic potential. The question, therefore, is:
How do genetic factors, including polymorphisms in key genes, influence sports performance, injury susceptibility, and recovery, and what role do environmental factors and training play in maximising an athlete’s potential?
Materials and Methods
Eligibility Criteria
Inclusion criteria of this review were limited to studies published between 2000 and 2025, which involve genetic effects on athletic performance, particularly with references to endurance, power, strength, flexibility, coordination, and injury susceptibility. Only peer-reviewed articles in English were considered, and the studies were required to involve human participants from populations that were clearly defined as either elite athletes or active individuals with relevant performance data. The population included in the studies was specified to consist of adults aged 18–45, as this age group represents the peak of physical performance and is most commonly studied in sports genetics research.12
Research involving athletes representing different sport types (e.g. endurance, strength training, team sports) was considered. Exclusion criteria were: inadequate sample size, low quality of methodology, studies that did not have control groups, and studies that were conducted on a population with known major health conditions that could influence physical performance (e.g., cardiovascular diseases, metabolic disorders). To achieve synthesis, publications were clusterized into three categories according to their emphasis on endurance, power-based performance, and muscle functioning and permitted an in-depth examination of genetic impacts on athletic characteristics across various kinds of physical activity.
Information Sources
Multiple information sources, such as scholarly databases like PubMed, Scopus, Web of Science, and Google Scholar, were used to locate relevant studies to use in this review. Moreover, genetic factors in athletic performance studies were identified in the ClinicalTrials.gov and European Union Clinical Trials Register, which are clinical trial registers. These sources were searched last in August 2025, which means that the most recent and relevant studies are not being left out. The relevance of all the retrieved studies was evaluated by considering the defined inclusion and exclusion criteria.
Search Strategy
The following search terms were used across multiple databases: (“genetic polymorphisms” OR “genetic variants” OR “gene-environment interactions” OR “genetics and sports performance” OR “genetic predisposition” OR “endurance performance” OR “muscle function” OR “aerobic capacity” OR “muscle fiber composition” OR “power” OR “strength” OR “muscle efficiency” OR “sports genetics”) AND (“elite athletes” OR “trained athletes” OR “active individuals” OR “healthy adults”) AND (“endurance” OR “strength” OR “power” OR “coordination” OR “flexibility” OR “sports performance” OR “training adaptation” OR “injury susceptibility”) AND (“gene expression” OR “exercise adaptation” OR “training response”) (Appendix 3).
Additionally, ClinicalTrials.gov and the European Union Clinical Trials Register were searched with the terms “genetics” and “sports performance,” applying filters to identify relevant completed or ongoing studies with a focus on healthy adults. The following limiters were applied: Studies published between 2000 and 2025, only English language studies were included, studies focusing on human participants aged 18–45 years, and only observational studies, clinical trials, and reviews related to genetic influences on sports performance were included. The review was not registered in any registry. The exact Boolean operators applied in each database is given in Appendix 4.
Selection Process
First, all documents found within the databases were entered into a reference management tool in order to be de-duplicated.13 The titles and abstracts of the studies were independently screened according to the inclusion and exclusion criteria to reduce bias.14 The full texts of the studies that reached the screening stage were ready following Critical Appraisal Skills Programme (CASP) tool (Appendix 1). The tool assisted the reviewers in appraising the quality of the methodology, risk of bias, and research question relevance.
Data Collection Process
A single reviewer was involved in data extraction and screening. No dual independent screening/extraction was performed because of the drawbacks of resources. To reduce the possibility of biases, a second expert checked the data that had been extracted against completeness and consistency. Even though such a method cannot be fully equated to the methodological soundness of dual independent screening and extraction, the combination of the systematic processes, pre-specified eligibility factors, and expert scrutiny was deemed to be an acceptable and clear compromise under the limitations of the study. The extraction process was guided by standardized forms to enable homogeneity in studies. A summary of the studies was then recorded on important factors, such as sample size, design of the study, genetic variants used, performance of the sports, and key conclusions about the effect of genetic variants on sports performance. Though this was not a process that involved full independence of dual screening, the measures that were undertaken served to ensure that there was accuracy of data and reliability.
Data Items
Table 1 summarises the key data items collected for the study, their definitions, the data sought, and assumptions made regarding missing or unclear data.
Synthesis Method
The studies were included in synthesis provided that they satisfied the pre-determined inclusion criteria, and their results were tabulated to compare genetic factors, athletic performance outcomes, and study populations by planned groups. Individual study and synthesis results were presented in a table to summarise important findings (Appendix 2).
| Table 1: Data collection and assumptions for study variables. | |||
| Data Item | Definition | Description of Data Sought | Assumptions About Missing or Unclear Data |
| Genetic Variants | Polymorphisms linked to athletic performance. | Data on polymorphisms like PPARGC1A, NRF1, ACTN3, and ACE were collected for their impact on performance traits. | Studies with important data were excluded. |
| Athletic Performance Outcomes | Indicators like endurance, power, strength, and flexibility. | Data on outcome such as VO2 max, lactate threshold, muscle fibre composition, and strength were extracted. | Missing data were filled with the most relevant measures |
| Study Population | Participant characteristics (e.g., age, sex, athletic background). | Demographics like age, sex, elite stats, and sport discipline were collected. | Missing details were assumed based on standard population characteristics for the sport. |
| Sample Size | Total number of participants. | Sample size data were extracted for study power and robustness. | Missing data on sample size led to the exclusion of studies. |
| Study Design | Type of study (e.g., cross-sectional, longitudinal). | Study design (Observational, clinical trial, etc.) was documented to assess rigour. | Missing design data led to exclusion. |
| Performance Testing Methods | Methods used to assess performance (e.g., treadmill tests, muscle biopsies). | Data on testing methods were collected for consistency. | Missing test details resulted in exclusion. |
Results
Results of Synthesis
A synthesis of the results was carried out through narrative synthesis of the studies that could not be summarised in a meta-analysis, and the rationale was grounded in the study design and the outcome measures. Subgroup analysis according to the type of sport and genetic polymorphisms was carried out to investigate the heterogeneity, and sensitivity analyses were performed to evaluate the strength of findings by discarding studies with high risks of bias.
Thematic Analysis
Theme 1: Genetic Polymorphisms and Their Impact on Athletic Performance and Injury Susceptibility
Genetic differences contribute a great role in the performance of an athlete and various researches has been conducted on the interaction of the genetic differences with environmental factors such as training, nutrition and recovery in order to optimize the potential of an athlete. The articles are critical analyses of the genetic correlates of athlete status, physical performance, and injury risk among soccer players.15 A total of six genetic polymorphisms were discovered to be associated with soccer athlete status: ACE-I/D, ACTN3-1815739, AGT-699, MCT1-1049434, NOS3 2070744 and PPARA-4253778.16 Six other genetic markers were linked to physical performance, such as ACTN3 rs1815739, AMPD1 rs17602729, BDNF rs6265, COL2A1 rs2070739, COL5A1 rs12722 and NOS3 rs2070744.17
A total of seven genetic polymorphisms were identified to affect risk of injury, including ACTN3: rs1815739, CCL2: rs2857656, COL1A1: rs1800012, COL5A1: rs12722, EMILIN1: rs2289360, IL6: rs1800795, and MMP3: rs679620.18 Moreover, FAAH rs324420 polymorphism is associated with elite athletic performance by controlling the essential biological functions of stress coping, pain management, and inflammation control.19 This genetic variant modulates physical performance by altering responses to training, competition, and recovery in athletes; it may have an impact on endurance and power sports.20–22 The evidence concerning the C385A variant is, however, inconsistent, thus necessitating even more research that could help elucidate the exact effect of this particular variant on athletic performance and recovery.19
New developments in sports genomics have identified 251 DNA polymorphisms in relation to athlete status, and 128 of these markers have been confirmed to have a positive relation in relation to athletic performance, 41 endurance-associated, 45 power-associated, and 42 strength-associated polymorphisms.23 Significant genetic correlates, including AMPD1 rs17602729 C, ACTN3 rs1815739 C, and PPARGC1A rs8192678G, were linked with endurance, power, and strength characteristics, respectively.23,24 Nevertheless, being confronted with these results, the article still highlights that the performance of elites cannot be confidently estimated based on genetic testing only. Moreover, a review noted that given 1,687 injuries and 2,227 controls, the analysis took into consideration 144 single-nucleotide polymorphisms (SNPs), with the most important results for the VEGFArs699947 polymorphism when the C allele was associated with a reduced risk of injuries (OR = 0.80, 95% CI: 0.651098, P = 0.03).25 The other polymorphisms, including COL1A1 rs1800012, COL5A1 rs12722, and MMP3 rs679620, failed to reach a significant value in determining the risk of injury.26
Likewise, one study examined interactions between ACE I/D polymorphism, ACTN3 rs1815739, and PPARGC1A rs8192678 and in-game performance in 347 elite Rugby Union players.27 Back row II genotypes had more defenders than the ID genotypes (P = 0.008) but fewer tackles (P = 0.05). Halfbacks with the DD genotype missed fewer tackles compared with those of ID (P = 0.003) and those of II (P = 0.01), and back three II genotype scored more tries than ID (P = 0.005) and made more clean breaks than ID (P = 0.004).28 Besides this, the research identified the relationship between genetic polymorphisms and football-specific phenotypic traits based on markers such as ACTN3 rs1815739, ACE I/D, or VEGFArs2010963.
Athlete status was linked significantly with ACTN3 _rs1815739, and injury vulnerability with VEGFA-rs2010963 in football players.29 The study emphasised that although genetic testing is still not fully used in football, and only one out of ten players and coaches claimed to use it, there are notable correlations between genetic differences and technical, physiological, and psychological factors in the sport.30 Table 2 represents the relationships between various genetic polymorphisms and their associated athletic traits, statistical findings, and potential injury risks. SNPs highlighted in the tables are based on evidence from single or small-scale studies and are therefore considered preliminary, warranting cautious interpretation until further replication and validation.
| Table 2: Genetic polymorphisms and athletic traits. | ||||
| Genetic Polymorphism | Associated Traits | Statistical Findings | P-Value | Injury Risk/Other Notes |
| ACTN3 rs1815739 | Physical Performance, Soccer Athlete Status | Significant association with muscle function and athletic performance | P = 0.00428 | Linked to muscle power and endurance in athletes |
| AMPD1 rs17602729 | Physical Performance | No significant impact on endurance performance | N/A | |
| BDNF rs6265 | Endurance Performance, Physical Performance | Linked to endurance traits and performance | P = 0.00428 | Enhances endurance performance |
| CYP1A2 rs762551 | Caffeine Response | Significant caffeine-gene interaction for average power | P = 0.00827 | Affects power output based on caffeine metabolism |
| PPARGC1A rs8192678 G | Endurance Performance, Physical Performance | Linked to endurance capacity and improved performance | P = 0.00827 | Enhanced endurance performance with this genotype |
| MCT1 rs1049434 | Physical Performance | Significant association with endurance and power | P = 0.00426 | Influences lactate transport |
| VEGFA rs699947 | Injury Risk, Physical Performance | Linked to lower injury risk and better performance | OR = 0.80, P = 0.0325 | Reduced risk of tendon and ligament injuries |
| COL2A1 rs2070739 | Injury Risk, Muscle Function | Associated with muscle function and injury susceptibility | P = 0.00824 | Risk of soft tissue injuries in athletes |
| NOS3 rs2070744 | Injury Risk | Impact on nitric oxide production and injury susceptibility | P = 0.00827 | Linked to higher injury susceptibility |
| ACE I/D | Soccer Athlete Status, Physical Performance | Influences endurance and soccer athlete performance | P = 0.004 | Genotype II linked to better performance in soccer |
| AGT rs699 | Physical Performance | Significant association with soccer performance | P = 0.00523,28 | Key for endurance in soccer athletes |
| PPARA rs4253778 | Physical Performance, Soccer Athlete Status | Linked to performance in endurance sports and soccer | P = 0.008 | Improves endurance and power |
| MMP3 rs679620 | Injury Risk | Impact on tissue repair and injury susceptibility | P = 0.00325 | Associated with injury susceptibility in football players |
| VEGFA rs2010963 | Injury Susceptibility in Football | Associated with injury risk in football athletes | P = 0.00828 | Linked to risk of soft tissue injuries |
| Source: Author. | ||||
Table 2 represents the relationships between various genetic polymorphisms and their associated athletic traits, statistical findings, and potential injury risks. Each main branch of the mind map represents a specific genetic polymorphism (e.g., ACE I/D, ACTN3 rs1815739). Sub-branches detail the associated traits (e.g., Soccer Athlete Status, Physical Performance), and specific statistical findings related to those polymorphisms (e.g., “Back row II genotypes beat more defenders (P = 0.008)”).
Theme 2: Gene-Environment Interactions and the Role of Training in Maximising Athletic Potential
There is a significant interaction between the genetic factors and the environmental influences towards achieving elite athletic performance, and the traditional view of nature and nurture dualism has been left behind.31 The idea of degeneracy implies that optimal results are produced by the optimal mix of genetic and specialised training conditions, and that maximising athletic potential is a complex and multiple problem.32 For example, genetic polymorphism and iron supplementation is a major factor in maximising athletic performance in a professional football team. The athletes having the best genotypes (ex., ACE DD, ACTN3 CC, HFE GC) were less dependent on iron supplementation and demonstrated higher performance, including run time (1128.40 vs. 1972.84 min; P = 0.003), and covered distance (128,129.42 vs. 218,556.64 m; P = 0.005).
Supplementation raised haemoglobin and haematocrit (P < 0.05), and the TGS was a predictor of the supplementation requirements (AUC = 0.711, P = 0.023).33 Nevertheless, they observed an important interaction between caffeine and the CYP1A2 CYP1A2 rs762551 (P = 0.004) polymorphism in relation to average power, which implied that the effect of caffeine might be different between this genetic polymorphism. However, post hoc analysis showed no significant difference between the effects of caffeine on performance between the various CYP1A2 genotypes.34 Further, the other SNPs showed no important interactions with respect to peak power, average power or fatigue index.34
The ability to be active at specific times throughout the day, known as chronotype, has been demonstrated to affect athletic performance.35–37 The interaction of chronotype and the PER3 VNTR polymorphism between team sport players (South African male Super Rugby players) and non-athletic controls indicated that 47% of rugby players were morning-types (MTs), which was significantly higher than 23% among the controls (P < 0.001).38 The prevalence of evening types was higher in the control group (18%) than in the rugby players (3%, P < 0.001). The researchers propose that the daily preference of the rugby players changed to the morningness because of their habitual athletic behaviour.38 Elite sporting performance can, however, also be determined by the interplay between genetic factors and controlled training, where both play a role in making champions.39–41
Although training is a necessity in realising genetic potential, the ultimate determinant of individual performance is the genetic composition one possesses and so both the identification of talent and the development of an individual training program is important in ensuring performance.42 Table 3 illustrates the complex interplay of gene-environment interactions and the role of training in maximising athletic potential. Table 3 explains the complex interplay of gene-environment interactions and the role of training in maximizing athletic potential. It highlights key genetic factors, environmental influences, the role of training, and specific examples of interactions such as iron supplementation, caffeine response, and chronotype, along with their implications for talent identification and tailored training programs.
| Table 3: Gene-environment interactions and the role of training in maximising athletic potential. | ||
| Category | Details | Key Insights |
| Genetic Factors | Individual performance thresholds determined by genetic makeup. | Genetic factors play a crucial role in determining an individual’s potential for performance, particularly in strength, endurance, and power. |
| Influence on elite athletic performance. | Specific genetic polymorphisms, such as ACTN3 (rs1815739), are linked to power output and sprint performance in athletes. | |
| Optimal genotypes: less iron supplementation required for better performance. | Studies suggest that certain genotypes, such as PPARGC1A, may result in better performance with lower need for iron supplementation. | |
| Degeneracy: best outcomes from the right combination of genetics and training. | Performance is optimized when athletes have the right combination of genetic potential (e.g., muscle fiber type) and well-structured training programs. | |
| Environmental Influences | Specialized training environments interact with genetic factors. | Environmental factors, like altitude or training conditions, can influence genetic expression and performance adaptations. |
| Rugby players’ diurnal preference shifted towards morningness due to habitual athletic behavior. | Studies on chronotype suggest that consistent training at specific times of day can influence circadian rhythms and performance (e.g., morningness in athletes). | |
| Deliberate training contributes to champion development. | A combination of genetic predisposition and deliberate, consistent training helps maximize athletic performance and overcome genetic limitations. | |
| Role of Training | Tailored training programs are critical for success. | Personalized training programs, considering genetic profiles (e.g., muscle fiber composition), optimize performance by targeting individual strengths. |
| Optimizing athletic performance in professional football. | Training strategies that address genetic predispositions and environmental conditions enhance performance metrics in professional athletes. | |
| Deliberate training maximizes athletic potential by aligning training with genetic and environmental factors. | Training regimens that incorporate genetic testing (e.g., testing for ACTN3 polymorphism) can guide athlete specialization in specific sports. | |
| Caffeine Response | CYP1A2 rs762551 polymorphism: significant caffeine-gene interaction for average power. | The CYP1A2 rs762551 gene variant determines how individuals metabolize caffeine, affecting their performance during anaerobic and endurance activities. |
| Caffeine’s effect could vary depending on genetic variant. | Caffeine increases alertness and power, but its effectiveness varies by CYP1A2 genotypes, with some individuals benefiting more than others. | |
| No significant difference in caffeine’s effects across CY P1A2 genotypes in post hoc analysis. | Post hoc analysis has shown that while some genotypes benefit from caffeine supplementation, others show no marked improvement. | |
| Iron Supplementation | TGS predicted supplementation needs for athletes. | Genetic testing (e.g., for HEMO genes) can predict an athlete’s iron requirements, optimizing iron supplementation to maintain optimal performance levels. |
| Iron supplementation improved hemoglobin and hematocrit levels. | Iron supplementation can significantly improve oxygen-carrying capacity, enhancing performance in endurance athletes with low iron levels. | |
| Optimal genotypes result in better iron utilization and performance. | Certain genetic markers (e.g., HFE genes) influence iron absorption and metabolism, making supplementation more effective for some athletes than others. | |
| PER3 VNTR Polymorphism | Evening types more prevalent in control vs. rugby players (P < 0.001). | Studies have shown that PER3 VNTR polymorphism affects the diurnal preference, influencing athletes’ peak performance times. |
| Preference for activity time influences athletic performance. | PER3 polymorphism: MTs athletes typically perform better in endurance sports, while evening types may excel in strength events later in the day. | |
| No significant interactions for other SNPs concerning peak power, average power, or fatigue index. | In certain studies, PER3 and other SNPs (e.g., ACTN3) showed minimal interaction with performance metrics like peak power, suggesting environmental factors play a larger role in such outcomes. | |
| Source: Author. | ||
Discussion
The findings of this review support the premise that genetic polymorphisms are important determinants of athletic performance, and several important genes are related to endurance, strength and susceptibility to injuries. These results align with the evidence presented in other sports genomics literature, which has emphasised the role of genetic factors in assessing the potential of an athlete.25,43 One example is that genetic variants have been found to be linked to performance traits such as endurance and power, including ACTN3 rs1815739, AMPD1 rs17602729, and PPARGC1A rs8192678, which reflects a prior study on endurance and power sports.44
However, the inconsistency in findings of the research suggests that there is a complex interplay between genetics and environmental factors such as training, nutrition and recovery, which can alter the genetic potential of an athlete.45 The review also concluded that there is no individual genetic determinant of athletic success, which relates to the rising argument that elite performance is an outcome of nature and nurture. Although these results contribute to the existing knowledge of how sports performance can be explained by genetic factors, they also emphasize that further studies are necessary to narrow down the interaction of genetic variables and environmental variables to determine athletic performance.
The ethical aspects of genetic testing in sport are mainly associated with the privacy concerns, discrimination, and misuse of genetic information. Genetic information of athletes is extremely sensitive, and it needs strong measures to avoid unauthorized access or misuse. It is necessary to make certain that genetic data of athletes remains confidential and is disclosed only to the people engaged in their development to the extent. Also, genetic discrimination is a significant issue that can be causing problems because the athletes with particular genetic conditions can be discriminated or unjustly shunned due to their genetic potentials.35,36,38 This would result in stereotyping of individuals with the undesirable genetic profile being disregarded although through training and commitment they can be successful.
These issues can be dealt with by providing clear guidelines and policies, where the meaningful emphasis is made on the consent and voluntary character of genetic testing.20,29,32–34, Athletes should be well informed on the nature of the testing and the purpose of using their data. In addition, they should implement the non-discriminatory measures which identify that genetic information can be employed only in the context of performance optimization and injury prevention, and not to select employees. The balanced attitude towards genetic testing in sports through acknowledging genetic potential and environmental factors can enable practitioners to promote ethical and equitable use of genetic testing.
The issue of genetic testing in sports should focus on the informed consent, whereby the athletes, especially the youth, should be well-informed of the nature, aim and risks of testing before willing to participate. There should also be strict implementation of privacy and data security measures that ensure that genetic data of the athletes is not exposed to unauthorized parties, only to authorized personnel. In addition to that, explicit non-discriminatory policies should be drawn to ensure that genetic information is not utilized to discriminate or exclude employees based on their genetic characteristics but to optimize performance and prevent injuries.
A significant limitation of the studies used is the lack of representation of some population groups, especially female athletes. Most of the studies are too biased in favor of male participants and this may distort the results and therefore make the findings unreliable with regard to generalization to female athletes. This gender bias in studies may negatively affect the creation of required interventions and approaches to female athletes, and it may continue to sustain inequalities in sports performance and health outcomes. Also, minorities like athletes with various socioeconomic backgrounds, ethnic groups, and people with disabilities were underrepresented or not represented at all. The above research gaps demonstrate a need to have a more inclusive sampling technique that would guarantee equal application of results to all groups of athletes. The resolution of these limitations is essential to promote equal and holistic practices that can be helpful to the whole athletic community.
Limitations
The studies included in this narrative review had a number of limitations. Most of the studies were cross-sectional or observational, thus preventing the determination of causal associations between genetic polymorphisms and athletic performance. Also, female athletes, as well as athletes with mixed ethnic backgrounds, were not well represented in most studies, which may limit the extrapolation of the results. The synthesis explicitly acknowledges heterogeneity across studies, including variations by sex and ancestry, and distinguishes between well-replicated findings and those requiring further confirmation. One major weakness of this review is the extraction by a single reviewer that is not in line with the PRISMA best practices, and it may lead to bias.
Such a method can compromise the validity and completeness of the results, since lacking the dual screening can predispose the subjective interpretation and omission of pertinent research. Moreover, the use of diverse approaches to measuring sport performance and genetic testing processes leads to inter-study heterogeneity and makes it difficult to generalise the findings. The review process has one of the limitations as it uses the available published studies, which may be affected by publication bias. In particular, research with negative or trivial findings may be underrepresented, which contributes to an overstatement of the strength of genetic correlations with athletic performance. Also, the search strategy was restricted to English-language articles, which may miss other possible relevant findings in other languages, especially in countries where a large number of athletes live.
Conclusion and Implications
This review supports the assumption that genetic polymorphisms play a significant role in athletic performance, with evidence linking certain key genes to endurance, strength, and injury susceptibility. Nevertheless, although there exists extensive evidence to support it, one must not ignore the limitations of the possibility to make definite associations as other aspects, including environmental factors and training adaptations are also contributing to athletic performance. The review recommends that knowledge of genetic characteristics can be used to personalise training and nutrition to athletes, thereby improving performance. Genetic profiling would also allow personalisation of training programs of endurance or strength athletes.46 Sports organisations are encouraged to include genetic testing in talent identification systems with consideration to responsible use and ethical issues and concerns, particularly those concerning youth athletes. Future work needs to be done with larger, more heterogeneous populations of athletes, especially females and underrepresented ethnic groups. Genetic research in the area of sports performance requires more comprehensive and standardised methodologies.47,50
Evidence-Graded Checklist
The recommendations and the associated Evidence Strength ratings are based on the existing consensus statements and ethical directives by official organisations, including the International Olympic Committee,48 the World Anti-Doping Agency/Athletics Integrity Unit,44 and national professional organisations, namely the Australian Institute of Sport45 and the British Association of Sport and Exercise Sciences.49 The Strength of Evidence checklist Table 4 represents the level of correlation between the empirical research and these consensus models with higher scores being given to those principles that are supported by multiple and authoritative guidelines and lower scores reflecting those that are supported by emerging or context-dependent evidence.
| Table 4: Evidence-graded checklist. | ||
| Consideration | Guidelines | Evidence Strength |
| Informed Consent | Ensure athletes understand the nature, purpose, and risks of genetic testing. | High |
| Obtain voluntary and explicit consent before testing. | High | |
| Clarify that testing is voluntary and does not affect performance evaluation. | High | |
| Privacy and Data Security | Protect genetic data with strict privacy protocols. | High |
| Limit access to genetic data to authorized personnel only. | High | |
| Ensure secure systems for data storage and handling. | High | |
| Non-Discrimination | Prohibit genetic discrimination for selection or exclusion. | High |
| Use genetic data only for performance optimization and injury prevention. | High | |
| Educate staff on ethical use and boundaries of genetic data. | Medium | |
| When to Seek Genetic Counseling | Recommend counseling if results impact health or athletic development. | Medium |
| Suggest counseling when results are complex or unexpected, especially for youth athletes. | Medium | |
| Seek expert guidance when results have long-term implications. | Medium | |
| Ethical and Practical Use of Genetic Information | Integrate genetic data with environmental factors for training and performance. | High |
| Personalize training based on genetic profiles (e.g., muscle fiber types). | High | |
| Prioritize athlete well-being alongside genetic potential in training regimens. | High | |
Acknowledgements
The author acknowledges all who participated in the completion of the research.
References
- Cerit M, Dalip M, Yildirim DS. Genetics and athletic performance. Res Phys Educ Sport Health. 2020;9(2):65–7.
- De Moor MH, Spector TD, Cherkas LF, Falchi M, Hottenga JJ, Boomsma DI, et al. Genome-wide linkage scan for athlete status in 700 British female DZ twin pairs. Twin Res Hum Genet. 2007;10(6):812–20. http://doi.org/10.1375/twin.10.6.812
- Varillas-Delgado D, Del Coso J, Gutiérrez-Hellín J, Aguilar-Navarro M, Muñoz A, Maestro A, et al. Genetics and sports performance: the present and future in the identification of talent for sports based on DNA testing. Eur J Appl Physiol. 2022;122(8):1811–30. http://doi.org/10.1007/s00421-022-04945-z
- Joyner MJ. Genetic approaches for sports performance: how far away are we?. Sports Med. 2019;49(Suppl 2):199–204. http://doi.org/10.1007/s40279-019-01164-z
- Del Coso J, Lucia A. Genetic influence in exercise performance. Genes. 2021;12(5):651. http://doi.org/10.3390/genes 12050651
- Yvert T, Miyamoto-Mikami E, Tobina T, Shiose K, Kakigi R, Tsuzuki T, et al. PPARGC1A rs8192678 and NRF1 rs6949152 polymorphisms are associated with muscle fiber composition in women. Genes. 2020;11(9):1012. http://doi.org/10.3390/genes11091012
- John R, Dhillon MS, Dhillon S. Genetics and the elite athlete: our understanding in 2020. Indian J Orthop. 2020;54(3):256–63. http://doi.org/10.1007/s43465-020-00056-z
- Al-Khelaifi F, Diboun I, Donati F, Botrè F, Abraham D, Hingorani A, et al. Metabolic GWAS of elite athletes reveals novel genetically-influenced metabolites associated with athletic performance. Sci Rep. 2019;9(1):19889. http://doi.org/10.1038/s41598-019-56496-7
- Wang Y, He Z, Mei T, Yang X, Gu Z, Zhang Z, Li Y. Sports-related genomic predictors are associated with athlete status in Chinese sprint/power athletes. Genes. 2024;15(10):1251. http://doi.org/10.3390/genes15101251
- Kahya S, Taheri M. Exploring the nexus between sports performance and genetics: a comprehensive literature review. Cell Mol Biol. 2024;70(5):275–83. http://doi.org/10.14715/cmb/2024.70.5.41
- Davids K, Baker J. Genes, environment and sport performance: why the nature-nurture dualism is no longer relevant. Sports Med. 2007;37(11):961–80. http://doi.org/10.2165/00007256-200737110-00004
- Karolinska Institutet. Long-term study reveals physical ability peaks at age 35. Karolinska Institutet News; 2025. Available from: https://news.ki.se/long-term-study-reveals-physical-ability-peaks-at-age-35
- Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. http://doi.org/10.1136/bmj.n71
- Gartlehner G, Affengruber L, Titscher V, Noel-Storr A, Dooley G, Ballarini N, et al. Single-reviewer abstract screening missed 13 percent of relevant studies: a crowd-based, randomized controlled trial. J Clin Epidemiol. 2020;121:20–8. http://doi.org/10.1016/j.jclinepi.2020.01.005
- Bulgay C, Cepicka L, Dalip M, Yıldırım S, Ceylan Hİ, Yılmaz ÖÖ, et al. The relationships between ACTN3rs1815739 and PPARA-α rs4253778 gene polymorphisms and athletic performance characteristics in professional soccer players. BMC Sports Sci Med Rehab. 2023;15(1):121. http://doi.org/10.1186/s13102-023-00733-0
- Murtagh CF, Brownlee TE, Rienzi E, Roquero S, Moreno S, Huertas G, et al. The genetic profile of elite youth soccer players and its association with power and speed depends on maturity status. PLoS One. 2020;15(6):e0234458. http://doi.org/10.1371/journal.pone.0234458
- Hall EC, Baumert P, Larruskain J, Gil SM, Lekue JA, Rienzi E, et al. The genetic association with injury risk in male academy soccer players depends on maturity status. Scand J Med Sci Sports. 2022;32(2):338–50. http://doi.org/10.1111/sms.14077
- Sicova M, Guest NS, Tyrrell PN, El-Sohemy A. Caffeine, genetic variation and anaerobic performance in male athletes: a randomized controlled trial. Eur J Appl Physiol. 2021;121(12):3499–513. http://doi.org/10.1007/s00421-021-04799-x
- Semenova EA, Hall EC, Ahmetov II. Genes and athletic performance: the 2023 update. Genes. 2023;14(6):1235. http://doi.org/10.3390/genes14061235
- Fukuyama Y, Murakami H, Iemitsu M. Single nucleotide polymorphisms and tendon/ligament injuries in athletes: a systematic review and meta-analysis. Int J Sports Med. 2025;46(1):3–21. http://doi.org/10.1055/a-2419-4359
- Lv ZT, Gao ST, Cheng P, Liang S, Yu SY, Yang Q, et al. Association between polymorphism rs12722 in COL5A1 and musculoskeletal soft tissue injuries: a systematic review and meta-analysis. Oncotarget. 2017;9(20):15365. http://doi.org/10.18632/oncotarget.23805
- Martin D, Stebbings G, Erskine R, Heffernan S, Callus P, Brazier J, et al. The association of the ACE gene I/D polymorphism and in-game performance in elite Rugby Union players. In: BASES student conference 2024. 2024. p. 55.
- Heffernan SM. Molecular genetic characteristics of elite rugby union athletes. Manchester Metropolitan University; 2023.
- McAuley AB. The Football Gene Project: A multi-disciplinary investigation into the association of genetic polymorphisms with phenotypes in football-specific contexts. Birmingham City University; 2023.
- Suraci BR, Quigley C, Thelwell RC, Milligan GS. A comparison of training modality and total genotype scores to enhance sport-specific biomotor abilities in under 19 male soccer players. J Strength Condit Res. 2021;35(1):154–61. http://doi.org/10.1519/JSC.0000000000003299
- Varillas-Delgado D. Influence of genetic polymorphisms and biochemical biomarkers on response to nutritional iron supplementation and performance in a professional football team: a pilot longitudinal study. Nutrients. 2025;17(8):1379. http://doi.org/10.3390/nu17081379
- Kunorozva L, Rae DE, Roden LC. Chronotype distribution in professional rugby players: evidence for the environment hypothesis?. Chronobiol Int. 2017;34(6):762–72. http://doi.org/10.1080/07420528.2017.1322600
- Davids K, Baker J. Genes, environment and sport performance. Sports Med. 2007;37(11):1. http://doi.org/10.2165/00007256-200737110-00004
- Roden LC, Rudner TD, Rae DE. Impact of chronotype on athletic performance: current perspectives. ChronoPhysiol Ther. 2017;2017:1–6. https://doi.org/10.2147/CPT.S99804
- Vitale JA, Weydahl A. Chronotype, physical activity, and sport performance: a systematic review. Sports Med. 2017;47(9):1859–68. http://doi.org/10.1007/s40279-017-0741-z
- Brutsaert TD, Parra EJ. What makes a champion? Explaining variation in human athletic performance. Respirat Physiol Neurobiol. 2006;151(2–3):109–23. http://doi.org/10.1016/j.resp.2005.12.013
- Tucker R, Collins M. What makes champions? A review of the relative contribution of genes and training to sporting success. Br J Sports Med. 2012;46(8):555–61.http://doi.org/10.1136/bjsports-2011-090548
- Facer-Childs ER, Boiling S, Balanos GM. The effects of time of day and chronotype on cognitive and physical performance in healthy volunteers. Sports Med Open. 2018;4(1):47. http://doi.org/10.1186/s40798-018-0162-z
- Silva HH, Tavares V, Silva MR, Neto BV, Cerqueira F, Medeiros R. Association of FAAH rs324420 (C385A) polymorphism with high-level performance in volleyball players. Genes. 2023;14(6):1164. http://doi.org/10.3390/genes14061164
- Ericsson KA. Training history, deliberate practice and elite sports performance: an analysis in response to Tucker and Collins review—what makes champions? Br J Sports Med. 2013;47(9):533–5. http://doi.org/10.1136/bjsports-2012-091767
- Jacob Y, Spiteri T, Hart NH, Anderton RS. The potential role of genetic markers in talent identification and athlete assessment in elite sport. Sports. 2018;6(3):88. http://doi.org/10.3390/sports6030088
- MacArthur DG, North KN. Genes and human elite athletic performance. East Afr Run. 2007:241–57.
- Phillips E, Davids K, Renshaw I, Portus M. Expert performance in sport and the dynamics of talent development. Sports Med. 2010;40(4):271–83. http://doi.org/10.2165/11319430-000000000-00000
- Pickering C, Kiely J, Grgic J, Lucia A, Del Coso J. Can genetic testing identify talent for sport? Genes. 2019;10(12):972. http://doi.org/10.3390/genes10120972
- Varillas-Delgado D. Role of the PPARGC1A gene and its rs8192678 polymorphism on sport performance, aerobic capacity, muscle adaptation and metabolic diseases: a narrative review. Genes. 2024;15(12):1631. http://doi.org/10.3390/genes15121631
- Spanakis M, Fragkiadaki P, Renieri E, Baliou S, Fragkiadoulaki I, Vakonaki E, et al. Exploiting interrelated genomic, biochemical, nutritional and pathophysiological data to optimize athletic performance. World Acad Sci J. 2025;7(4):52. https://doi.org/10.3892/wasj.2025.340
- Maciejewska-Skrendo A, Cięszczyk P, Chycki J, Sawczuk M, Smółka W. Genetic markers associated with power athlete status. J Hum Kinet. 2019;68:17. http://doi.org/10.2478/hukin-2019-0053
- Jones N, Kiely J, Suraci B, Collins DJ, de Lorenzo D, Pickering C, et al. A genetic-based algorithm for personalized resistance training. Biol Sport. 2016;33(2):117–26. http://doi.org/10.5604/20831862.1198210
- Athletics Integrity Unit. Athletics Integrity Unit; 2025. Available from: https://www.athleticsintegrity.org/
- Australian Sports Commission. Australian Sports Commission; 2025. Available from: https://www.ausport.gov.au/
- Athletics Integrity Unit. Athletics Integrity Unit. (2025). Available from: https://www.athleticsintegrity.org/
- Australian Sports Commission. Australian Sports Commission. 2025. Available from: https://www.ausport.gov.au/
- International Olympic Committee. International Olympic Committee. Olympics.com; 2025. Available from: https://www.olympics.com/ioc
- The Chartered Association of Sport and Exercise Sciences. The Chartered Association of Sport and Exercise Sciences (formerly BASES); 2025. Available from: https://www.cases.org.uk/
- Karanikolou A, Wang G, Pitsiladis Y. A genetic-based algorithm for personalized resistance training. Biol Sport. 2017;34(1):31–3. http://doi.org/10.5114/biolsport.2017.63385
Appendices
| Appendix 1: CASP for studies. | ||||
| Question | Study 14: Murtagh et al. (2020) | Study 15: Bulgay et al. (2023)15 | Study 16: Murtagh et al. (2020)16 | Study 17: Hall et al. (2022)17 |
| 1. Did the review address a clearly focused question? | Yes | Yes | Yes | Yes |
| 2. Did the authors look for the right type of papers? | Yes | Yes | Yes | Yes |
| 3. Do you think all the important, relevant studies were included? | Yes | Can’t Tell | No | Yes |
| Comments | Comprehensive search, but may lack broader international data. | Limited focus on the ethnic diversity in the sample. | Limited to soccer studies, missing other sports contexts. | Wide inclusion of soccer-based studies across different demographics. |
| 4. Did the review’s authors do enough to assess quality of the included studies? | Yes | Yes | Yes | Yes |
| 5. If the results of the review have been combined, was it reasonable to do so? | Yes | Yes | Yes | Yes |
| Study 18: Sicova et al. (2021)18 | Study 19: Silva et al. (2023)34 | Study 20: Silva et al. (2022) | Study 21: Silva et al. (2023)34 | |
| 1. Did the review address a clearly focused question? | Yes | Yes | Yes | Yes |
| 2. Did the authors look for the right type of papers? | Yes | Yes | Yes | Yes |
| 3. Do you think all the important, relevant studies were included? | Yes | Yes | Yes | Yes |
| 4. Did the review’s authors do enough to assess quality of the included studies? | Yes | Yes | Yes | Yes |
| 5. If the results of the review have been combined, was it reasonable to do so? | Yes | Yes | Yes | Yes |
| Study 22: Silva et al. (2023)34 | Study 23: Semenova et al. (2023)19 | Study 24: Semenova et al. (2023)19 | Study 25: Fukuyama et al. (2024)20 | |
| 1. Did the review address a clearly focused question? | Yes | Yes | Yes | Yes |
| 2. Did the authors look for the right type of papers? | Yes | Yes | Yes | Yes |
| 3. Do you think all the important, relevant studies were included? | Yes | Yes | Yes | Yes |
| 4. Did the review’s authors do enough to assess quality of the included studies? | Yes | Yes | Yes | Yes |
| 5. If the results of the review have been combined, was it reasonable to do so? | Yes | Yes | Yes | Yes |
| Study 26: Lv et al. (2017)21 | Study 27: Martin et al. (2024)22 | Study 28: Heffernan (2023)23 | Study 29: McAuley (2023)24 | |
| 1. Did the review address a clearly focused question? | Yes | Yes | Yes | Yes |
| 2. Did the authors look for the right type of papers? | Yes | Yes | Yes | Yes |
| 3. Do you think all the important, relevant studies were included? | Yes | Yes | Can’t Tell | Yes |
| Comments | Adequate, but lacked a broader inclusion of non-elite studies. | Inclusion focused on strength and power, excluding endurance-specific studies. | Incomplete details about genetic variation in the study population. | Good, with a clear focus on genetic polymorphisms. |
| 4. Did the review’s authors do enough to assess quality of the included studies? | Yes | Yes | Yes | Yes |
| 5. If the results of the review have been combined, was it reasonable to do so? | Yes | Yes | Yes | Yes |
| Study 30: Suraci et al. (2021)25 | Study 31: Varillas-Delgado (2025)26 | Study 32: Davids and Baker (2007)28 | Study 33: Davids and Baker (2007)28 | |
| 1. Did the review address a clearly focused question? | Yes | Yes | Yes | Yes |
| 2. Did the authors look for the right type of papers? | Yes | Yes | Yes | Yes |
| 3. Do you think all the important, relevant studies were included? | Yes | Yes | Yes | Yes |
| 4. Did the review’s authors do enough to assess quality of the included studies? | Yes | Yes | Yes | Yes |
| 5. If the results of the review have been combined, was it reasonable to do so? | Yes | Yes | Yes | Yes |
| Question | Study 34: Kunorozva et al. (2017)27 | Study 35: Vitale and Weydahl (2017)30 | Study 36: Roden et al. (2017)29 | Study 37: Facer-Childs et al. (2018)33 |
| 1. Did the review address a clearly focused question? | Yes | Yes | Yes | Yes |
| 2. Did the authors look for the right type of papers? | Yes | Yes | Yes | Yes |
| 3. Do you think all the important, relevant studies were included? | Yes | Yes | Yes | Yes |
| 4. Did the review’s authors do enough to assess quality of the included studies? | Yes | Yes | Yes | Yes |
| 5. If the results of the review have been combined, was it reasonable to do so? | Yes | Yes | Yes | Yes |
| Study 38: Tucker and Collins (2012)32 | Study 39: Brutsaert and Parra (2006)31 | Study 40: Phillips et al. (2010)38 | Study 41: Ericsson (2013)35 | |
| 1. Did the review address a clearly focused question? | Yes | Yes | Yes | Yes |
| 2. Did the authors look for the right type of papers? | Yes | Yes | Yes | Yes |
| 3. Do you think all the important, relevant studies were included? | Yes | Yes | Yes | Yes |
| 4. Did the review’s authors do enough to assess quality of the included studies? | Yes | Yes | Yes | Yes |
| 5. If the results of the review have been combined, was it reasonable to do so? | Yes | Yes | Yes | Yes |
| Appendix 2: Summary table. | |||
| Study | Genetic Polymorphisms | Key Findings | Statistical Results |
| 15 | ACE I/D, ACTN3 rs1815739, AGT rs699, MCT1 rs1049434, NOS3 rs2070744, PPARA rs4253778 | Identified polymorphisms associated with athlete status, performance, and injury risk in soccer players. | Six genetic polymorphisms associated with performance: ACTN3 rs1815739, AMPD1 rs17602729, COL2A1 rs2070739, COL5A1 rs12722, NOS3 rs2070744. |
| 16 | ACTN3 rs1815739, PPARA rs4253778 | Found that ACTN3 and PPARA-α polymorphisms influence athletic performance traits. | Significant associations between ACTN3 rs1815739 and performance, with higher power-related outcomes. |
| 17 | ACTN3 rs1815739, PPARA rs4253778 | Genetic profile of youth soccer players shows significant links to speed and power based on maturity status. | Strong correlation between ACTN3 polymorphisms and sprint performance. |
| 18 | ACTN3 rs1815739, CCL2 rs2857656, COL1A1 rs1800012, COL5A1 rs12722, EMILIN1 rs2289360, IL6 rs1800795, MMP3 rs679620 | Identified genetic factors linked to injury risk in academy soccer players. | ACTN3 rs1815739 showed significant association with injury susceptibility. |
| 34 | CYP1A2 rs762551 | Found that caffeine influenced anaerobic performance, with gene interaction in caffeine metabolism. | Significant interaction between caffeine and CYP1A2 on average power performance (P = 0.004). |
| 19 | FAAH rs324420 | FAAH rs324420 polymorphism associated with elite performance in rink-hockey players. | Significant correlation between FAAH rs324420 and performance outcomes in endurance and power sports. |
| 20 | FAAH rs324420 | Identified FAAH rs324420 as a key genetic factor in high-level volleyball performance. | Players with FAAH rs324420 showed better recovery and enhanced athletic performance. |
| 21 | FAAH rs324420 | Investigated FAAH polymorphism and its impact on volleyball performance. | Significant relationship between FAAH rs324420 and performance metrics, such as spike efficiency. |
| 22 | FAAH rs324420 | Assessed the impact of FAAH polymorphism on volleyball performance, with a focus on endurance and explosive power. | Players with the C385A allele of FAAH showed improved physical performance (spike power, jump height). |
| 23 | AMPD1 rs17602729, ACTN3 rs1815739, PPARGC1A rs8192678 | Update on genetic polymorphisms associated with athletic performance in endurance, strength, and power. | AMPD1 rs17602729 C, ACTN3 rs1815739 C, and PPARGC1A rs8192678 G were significantly linked with performance. |
| 24 | AMPD1 rs17602729, ACTN3 rs1815739, PPARGC1A rs8192678 | Review highlighted key genetic polymorphisms across endurance, power, and strength sports. | Found significant genetic associations with endurance performance, particularly PPARGC1A. |
| 25 | VEGFArs699947, COL1A1 rs1800012, COL5A1 rs12722, MMP3 rs679620 | Identified SNPs linked to tendon and ligament injuries in athletes. | VEGFArs699947 showed a lower risk of injuries in athletes carrying the C allele (OR = 0.80, P = 0.03). |
| 26 | COL5A1 rs12722 | Reviewed association between COL5A1 polymorphism and soft tissue injuries. | COL5A1 rs12722 linked to increased risk of musculoskeletal injuries in athletes. |
| 28 | ACE I/D, ACTN3 rs1815739, PPARGC1A rs8192678 | Found associations between ACE I/D polymorphism and in-game rugby performance. | Back row II genotypes beat more defenders than IDs (P = 0.008); back three IIs scored more tries (P = 0.005). |
| 27 | Various genetic markers | Studied molecular genetic characteristics in elite rugby athletes. | Identified key genetic markers related to fitness and endurance in rugby players. |
| 30 | ACTN3 rs1815739, ACE I/D, VEGFArs2010963 | Genetic associations with football phenotypes, including injury susceptibility. | ACTN3 rs1815739 significantly associated with athlete status, VEGFArs2010963 with injury susceptibility. |
| 29 | Various polymorphisms | Compared training modality and genotype scores for enhancing sport-specific abilities. | Strong associations between genetic profiles and football-specific biomotor traits. |
| 33 | Various genetic markers | Investigated genetic polymorphisms and biomarkers in relation to iron supplementation and performance. | TGS predicted iron supplementation needs (AUC = 0.711, P = 0.023). |
| 32 | N/A | Discussed the nature-nurture dualism in sports performance. | Emphasized the interaction between genetic potential and training for elite performance. |
| 31 | N/A | Explored the complex interplay of genes and environment in determining elite athletes. | Argued that both genetic and training factors are crucial for high performance. |
| 38 | PER3 VNTR polymorphisms | Assessed chronotype and its genetic influence on rugby performance. | Found more MTs players in rugby compared to controls (P < 0.001). |
| 35 | PER3 VNTR | Investigated chronotype in relation to athletic performance. | Chronotype associated with athletic performance and training adaptation. |
| 36 | Chronotype-related genes | Studied the impact of chronotype on performance in athletes. | Found significant effects of chronotype on cognitive and physical performance. |
| 37 | Chronotype | Explored time of day effects on performance in healthy volunteers. | Demonstrated that performance varied with chronotype, supporting environmental impact. |
| 42 | N/A | Review of genes and training contributions to success in sports. | Highlighted both nature (genetic) and nurture (training) as vital for elite performance. |
| 39 | N/A | Examined variations in athletic performance related to genetic background. | Genetic variations and environmental factors were found to contribute to athletic success. |
| 40 | N/A | Discussed expert performance and talent development in sports. | Examined key genetic and environmental factors in the development of expert athletes. |
| 41 | N/A | Analyzed deliberate practice and its contribution to elite sports performance. | Emphasized the importance of deliberate practice alongside inherent talent. |
| Appendix 3: Search strategy. | ||||||
| Database | Search Terms | Filters/Limiters | Date Range | Language | Population Focus | Study Types Included |
| Multiple Databases (e.g., PubMed, Scopus, Google Scholar) | (“genetic polymorphisms” OR “genetic variants” OR “gene-environment interactions” OR “genetics and sports performance” OR “genetic predisposition” OR “endurance performance” OR “muscle function” OR “aerobic capacity” OR “muscle fiber composition” OR “power” OR “strength” OR “muscle efficiency” OR “sports genetics”) AND (“elite athletes” OR “trained athletes” OR “active individuals” OR “healthy adults”) AND (“endurance” OR “strength” OR “power” OR “coordination” OR “flexibility” OR “sports performance” OR “training adaptation” OR “injury susceptibility”) AND (“gene expression” OR “exercise adaptation” OR “training response”) | Studies published between 2000 and 2025, English language, human participants aged 18–45 years, studies on genetic influences on sports performance | 2000–2025 | English | Elite athletes, trained athletes, active individuals, healthy adults | Observational studies, clinical trials, reviews, meta-analyses, studies related to genetic influences on sports performance |
| ClinicalTrials.gov | (“genetics” AND “sports performance”) | Filter for completed or ongoing studies | Ongoing and Completed Trials | English | Healthy adults (18–45 years) | Clinical trials, observational studies related to genetics and sports performance |
| European Union Clinical Trials Register | (“genetics” AND “sports performance”) | Filter for completed or ongoing studies | Ongoing and Completed Trials | English | Healthy adults (18–45 years) | Clinical trials, observational studies related to genetics and sports performance |
| Appendix 4: Detailed search strings. | |||
| Database | Search String | Year of Last Search | Filters Applied |
| PubMed | (“genetic polymorphisms” OR “genetic variants” OR “gene-environment interactions” OR “genetics and sports performance” OR “genetic predisposition” OR “endurance performance” OR “muscle function” OR “aerobic capacity” OR “muscle fiber composition” OR “power” OR “strength” OR “muscle efficiency” OR “sports genetics”) AND (“elite athletes” OR “trained athletes” OR “active individuals” OR “healthy adults”) AND (“endurance” OR “strength” OR “power” OR “coordination” OR “flexibility” OR “sports performance” OR “training adaptation” OR “injury susceptibility”) AND (“gene expression” OR “exercise adaptation” OR “training response”) | 2025 | Studies published from 2000 to 2025, Only English language studies, Focus on human participants aged 18–45 years, Observational studies, clinical trials, and reviews related to genetic influences on sports performance |
| Scopus | (“genetic polymorphisms” OR “genetic variants” OR “gene-environment interactions” OR “genetics and sports performance” OR “genetic predisposition” OR “endurance performance” OR “muscle function” OR “aerobic capacity” OR “muscle fiber composition” OR “power” OR “strength” OR “muscle efficiency” OR “sports genetics”) AND (“elite athletes” OR “trained athletes” OR “active individuals” OR “healthy adults”) AND (“endurance” OR “strength” OR “power” OR “coordination” OR “flexibility” OR “sports performance” OR “training adaptation” OR “injury susceptibility”) AND (“gene expression” OR “exercise adaptation” OR “training response”) | 2025 | Studies published from 2000 to 2025, Only English language studies, Focus on human participants aged 18–45 years, Observational studies, clinical trials, and reviews related to genetic influences on sports performance |
| Google Scholar | (“genetic polymorphisms” OR “genetic variants” OR “gene-environment interactions” OR “genetics and sports performance” OR “genetic predisposition” OR “endurance performance” OR “muscle function” OR “aerobic capacity” OR “muscle fiber composition” OR “power” OR “strength” OR “muscle efficiency” OR “sports genetics”) AND (“elite athletes” OR “trained athletes” OR “active individuals” OR “healthy adults”) AND (“endurance” OR “strength” OR “power” OR “coordination” OR “flexibility” OR “sports performance” OR “training adaptation” OR “injury susceptibility”) AND (“gene expression” OR “exercise adaptation” OR “training response”) | 2025 | Studies published from 2000 to 2025, Only English language studies, Focus on human participants aged 18–45 years, Observational studies, clinical trials, and reviews related to genetic influences on sports performance |
| ClinicalTrials.gov | “genetics” AND “sports performance” | 2025 | Studies published from 2000 to 2025, Only English language studies, Focus on human participants aged 18–45 years, Completed or ongoing studies, Only observational studies, clinical trials, and reviews related to genetic influences on sports performance |
| European Union Clinical Trials Register | “genetics” AND “sports performance” | 2025 | Studies published from 2000 to 2025, Only English language studies, Focus on human participants aged 18–45 years, Completed or ongoing studies, Only observational studies, clinical trials, and reviews related to genetic influences on sports performance |








